PureTech Health plc (OTCMKTS:PTCHF) Short Interest Update

PureTech Health plc (OTCMKTS:PTCHF) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 36,518 shares, a decline of 16.1% from the November 30th total of 43,518 shares. Based on an average trading volume of 974 shares, the days-to-cover ratio is presently 37.5 days. Based on an average trading volume of 974 shares, the days-to-cover ratio is presently 37.5 days.

PureTech Health Stock Up 0.3%

PureTech Health stock opened at $1.71 on Wednesday. PureTech Health has a 52 week low of $1.27 and a 52 week high of $1.90. The company has a 50 day moving average price of $1.67 and a 200 day moving average price of $1.69.

About PureTech Health

PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.

The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.